Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion

References

• Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272: 1955–1958
   PubMed Web of Science ®Google Scholar
• Bhattacharya J, Peters PJ, Clapham PR. Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J Virol 2004; 78: 5500–5506
   PubMed Web of Science ®Google Scholar
• Broder CC, Dimitrov DS. HIV and the 7-transmembrane domain receptors. Pathobiology 1996; 64: 171–179
   PubMed Web of Science ®Google Scholar
• Campbell SM, Crowe SM, Mak J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 2001; 22: 217–227
   Google Scholar
• Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 1988; 331: 82–84
   PubMed Web of Science ®Google Scholar
• Earl PL, Doms RW, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 1990; 87: 648–652
   PubMed Web of Science ®Google Scholar
• Earl PL, Koenig S, Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J Virol 1991; 65: 31–41
   PubMedGoogle Scholar
• Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872–877
   PubMed Web of Science ®Google Scholar
• Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH, Jr, Blumenthal R. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J Virol 2007; 81: 5294–5304
   Google Scholar
• Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R. Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci USA 2004; 101: 15452–15457
   PubMed Web of Science ®Google Scholar
• Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, Rawat SS, Puri A, Durell S, Blumenthal R. The HIV Env-mediated fusion reaction. Biochim Biophys Acta 2003; 1614: 36–50
   PubMed Web of Science ®Google Scholar
• Hammache D, Yahi N, Maresca M, Pieroni G, Fantini J. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J Virol 1999; 73: 5244–5248
   PubMed Web of Science ®Google Scholar
• Horejsi V. The roles of membrane microdomains (rafts) in T cell activation. Immunol Rev 2003; 191: 148–164
   PubMed Web of Science ®Google Scholar
• Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J Virol 2000; 74: 6377–6385
   PubMed Web of Science ®Google Scholar
• Kotani M, Ozawa H, Kawashima I, Ando S, Tai T. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta 1992; 1117: 97–103
   PubMed Web of Science ®Google Scholar
• Kozak SL, Heard JM, Kabat D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J Virol 2002; 76: 1802–1815
   Web of Science ®Google Scholar
• Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001; 17: 1009–1019
   PubMed Web of Science ®Google Scholar
• Lippincott-Schwartz J, Presley JF, Zaal KJ, Hirschberg K, Miller CD, Ellenberg J. Monitoring the dynamics and mobility of membrane proteins tagged with green fluorescent protein. Methods Cell Biol 1999; 58: 261–281
   Google Scholar
• Markovic I, Clouse KA. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention. Curr HIV Res 2004; 2: 223–234
   Google Scholar
• Nayak DP, Hui EK. The role of lipid microdomains in virus biology. Subcell Biochem 2004; 37: 443–491
   PubMedGoogle Scholar
• Nguyen DH, Giri B, Collins G, Taub DD. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 2005; 304: 559–569
   PubMed Web of Science ®Google Scholar
• Pal R, Nair BC, Hoke GM, Sarngadharan MG, Edidin M. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1). J Cell Physiol 1991; 147: 326–332
   Google Scholar
• Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem 2003; 278: 3153–3161
   PubMed Web of Science ®Google Scholar
• Pohlmann S, Reeves JD. Cellular entry of HIV: evaluation of therapeutic targets. Curr Pharm Des 2006; 12: 1963–1973
   PubMedGoogle Scholar
• Popik W, Alce TM. CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J Biol Chem 2004; 279: 704–712
   PubMed Web of Science ®Google Scholar
• Popik W, Alce TM, Au WC. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol 2002; 76: 4709–4722
   PubMed Web of Science ®Google Scholar
• Pucadyil TJ, Chattopadhyay A. Effect of cholesterol on lateral diffusion of fluorescent lipid probes in native hippocampal membranes. Chem Phys Lipids 2006; 143: 11–21
   PubMed Web of Science ®Google Scholar
• Puri A, Paternostre M, Blumenthal R. Lipids in viral fusion. Methods Mol Biol 1906; 199: 61–81
   Google Scholar
• Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology 2004; 318: 55–65
   Google Scholar
• Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J Virol 2004; 78: 7360–7368
   Google Scholar
• Rawat SS, Johnson BT, Puri A. Sphingolipids: modulators of HIV-1 infection and pathogenesis. Biosci Rep 2005; 25: 329–343
   Google Scholar
• Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A. Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion. Glycoconj J 2006; 23: 189–197
   Google Scholar
• Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, DeMartino JA, DiSalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol 2001; 75: 3779–3790
   PubMed Web of Science ®Google Scholar
• Steffens CM, Hope TJ. Localization of CD4 and CCR5 in living cells. J Virol 2003; 77: 4985–4991
   Google Scholar
• Steffens CM, Hope TJ. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol 2004; 78: 9573–9578
   Google Scholar
• Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, Ruscetti FW, Wang JM, Blumenthal R. Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 2002; 76: 11584–11595
   PubMed Web of Science ®Google Scholar
• Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol 2005; 79: 12231–12241
   Google Scholar
• Yamamura S, Handa K, Hakomori S. A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. Biochem Biophys Res Commun 1997; 236: 218–222
   Google Scholar